1 |
B. Y. Ahn, J. M. Han, and S. C. Hong, "Design of Integrated Retrieval System for Bioinformatics," 2007 KoCon Autumn Comprehensive Academy Conference, Vol. 5, No. 1, 2007, pp. 11-14.
|
2 |
H. Y. Jung, S. J. Park, and S. H. Park, "Bioinformatics Technology," Electronics and Telecommunications Trends, Vol. 20, No. 5, 2005, pp. 93-104.
|
3 |
S. J. Lee, H. S. Yong, "Development of Integrated Retrieval System of the Biology Sequence Database Using 11 Service," The KIPS Transactions:PartD, Vol. 11D, No. 4, 2004, pp. 755-764.
DOI
|
4 |
D. S. Wishart, C. Knox, A. C. Guo, S. Shrivastava, M. Hassanali, P. Stothard, Z. Chang, and J. Woolsey, "DrugBank: a comprehensive resource for in silico drug discovery and exploration," Nucleic Acids Research, Vol. 34, 2006, pp, D668-D672.
DOI
ScienceOn
|
5 |
W. Yang, J. Soares, P. Greninger, E. J. Edelman, H. Lightfoot, S. Forbes, N. Bindal, D. Beare, J. A. Smith, I. R. Thompson, S. Ramaswamy, P. A. Futreal, D. A. Haber, M. R. Stratton, C. Benes, U. McDermott, and M. J. Garnett, "Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells," Nucleic Acids Research, Vol. 41, 2013, pp. D955-D961.
DOI
|
6 |
Y. H. Choi, "Implementation of WSBAT: 11 Services based Biodata Analysis Tool," Graduate School of Sejong University, Master's thesis, 2004.
|
7 |
B. A. Aksoy, J. Gao, G. Dresdner, W. Wang, A. Root, X. Jing, E. Cerami, and C. Sander, "PiHelper: An Open Source Framework for Drug-Target and Antibody-Target Data," Bioinformatics, 2013.
|
8 |
J. S. Sohn, D. H. Kim, and I. J. Chung, "Representation of drug informations and their relations using ontology," Proceeding of Korea Computer Congress , Vol. 37, No. 1(C), 2010, pp. 317-322.
|
9 |
H. S. Jung, B. R. Hyun, S. H. Jung, W. H. Jang, and D. S. Han, "Drug Target Protein Prediction using SVM," KISS Korea Computer Congress, Vol. 34, No. 2(B), 2007, pp. 17-21.
|
10 |
Korea Pharmaceutical Information Service, http://www.kpis.or.kr/
|
11 |
NCBI Resource Coordinators, "Database resources of the National Center for Biotechnology Information," Nucleic Acids Research, Vol. 41, 2013, pp. D8-D20.
DOI
|
12 |
EMBL, http://www.embl.org/
|
13 |
P. W. Rose, C. Bi, W. F, Bluhm, C. H. Christie, D. Dimitropoulos, S. Dutta, R. K, Green, D. S. Goodsell, A. Prlic, M. Quesada, G. B. Quinn, A. G. Ramos, J. D. Westbrook, J. Young, C. Zardecki, H. M. Berman, and P. E. Bourne, "The RCSB Protein Data Bank: new resources for research and education," Nucleic Acids Research, Vol. 41, 2013, pp. D475-D482.
DOI
|
14 |
Guideline on Characterisation and Specifications for Therapeutic Monoclonal Antibody Products. 2011. Korea Food and Drug Administration.
|
15 |
ICH Q6B "Test Procedures and Acceptance Criteria for Biotechnological/Biological Products" (CPMP/ICH/365/96). 1999. European Medicines Agency.
|
16 |
Guideline on Development, Production, Characterization and Specifications for Monoclonal Antibodies and Related Products. 2009. European Medicines Agency.
|
17 |
D. K. Han, "A study on the media of bio-information based on 3D modeloing for protein tertiary structure," Korean German Institute of Technology, Master's thesis, 2012.
|
18 |
D. H. Im, "Trends of Bioinformatics for Establishing a Science-Technology-Oriented Society in the 21st Century," Graduate School of Sejong University, Master's thesis, 2004.
|
19 |
J. H. Byeon, Y. J. Choi, J. H. Lee, and J. K. Suh, "The Present Situation Analysis on Services of Protein Drug Information," Proceedings of the Korea Information Processing Society Conference, 2014.
|